ISBN: 978-1-4731-3093-7 Study Risk tool Population Outcomes No of events (%) Study design Allen Seattle Heart Failure Model MAGGIC project heart failure risk score Ambulatory people with heart failure, 21 years of age or older. Age (mean SD) (years): 75.1 Male %: 52% Ejection fraction: Family origin not reported Setting: Multicentre Country: USA Follow-up: Not reported Participants recruited between Mortality at 1 year AUCSensitivit y Specificity PPV NPV Hosmer- Lemeshow test Mortality at 1 Retrospective cohort Franke nstein Untitled risk +NT-proBNP) People with heart failure due to left ventricular systolic dysfunction Male %: 76 Family origin not reported Setting: Castle Hill Hospital, Hull Country: UK Follow-up: median 32 months Participants recruited between November 2001 and October Mortality at 1 year AUC Mortality at 1 Retrospective cohort Chronic Heart Failure Advanced heart failure and palliative care NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 Study Risk tool Population Outcomes No of events (%) Study design Kanwa r HeartMate II Risk Score People with HF who received a continuous flow LVAD as the primary implant between 2010 and 2015 (INTERMACS registry). Age, years (mean (SD)): 57(13) Female %: 21 Family origin not reported Setting: Multicentre (over 150 hospitals) Country: United States Follow up: median 3.8 years Participants recruited between Mortality at 1 year AROC Mortality at 1 deaths) Retrospective cohort Kao Seattle Heart Failure Model People with heart failure due to left ventricular systolic dysfunction Male %: 76 Family origin not reported Setting: Castle Hill Hospital, Hull Country: UK Mean follow up not reported Participants were recruited previous to 2001 Mortality at 1 year AUC Predicted versus year mortality Mortality at 1 Retrospective analysis of RCT data Chronic Heart Failure Advanced heart failure and palliative care NICE 2018. All rights reserved. Subject to Notice of rights. 